v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 6,272 $ 3,871 $ 11,401 $ 7,076
General and administrative 4,357 3,002 8,480 5,860
Total operating expenses 10,629 6,873 19,881 12,936
Loss from operations (10,629) (6,873) (19,881) (12,936)
Non-operating income:        
Interest income 1,024 272 1,869 522
Total non-operating income 1,024 272 1,869 522
Net loss $ (9,605) $ (6,601) $ (18,012) $ (12,414)
Per share information:        
Net loss per common share, basic (in dollars per share) $ (0.05) $ (0.07) $ (0.10) $ (0.13)
Net loss per common share, diluted (in dollars per share) $ (0.05) $ (0.07) $ (0.10) $ (0.13)
Weighted-average common shares outstanding, basic (in shares) 189,183,620 98,558,567 180,878,720 93,189,273
Weighted-average common shares outstanding, diluted (in shares) 189,183,620 98,558,567 180,878,720 93,189,273